Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis.

Kuppers DA, Arora S, Lim Y, Lim AR, Carter LM, Corrin PD, Plaisier CL, Basom R, Delrow JJ, Wang S, Hansen He H, Torok-Storb B, Hsieh AC, Paddison PJ.

Nat Commun. 2019 Oct 10;10(1):4596. doi: 10.1038/s41467-019-12518-6.

2.

The androgen receptor regulates a druggable translational regulon in advanced prostate cancer.

Liu Y, Horn JL, Banda K, Goodman AZ, Lim Y, Jana S, Arora S, Germanos AA, Wen L, Hardin WR, Yang YC, Coleman IM, Tharakan RG, Cai EY, Uo T, Pillai SPS, Corey E, Morrissey C, Chen Y, Carver BS, Plymate SR, Beronja S, Nelson PS, Hsieh AC.

Sci Transl Med. 2019 Jul 31;11(503). pii: eaaw4993. doi: 10.1126/scitranslmed.aaw4993.

3.

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.

Labrecque MP, Coleman IM, Brown LG, True LD, Kollath L, Lakely B, Nguyen HM, Yang YC, da Costa RMG, Kaipainen A, Coleman R, Higano CS, Yu EY, Cheng HH, Mostaghel EA, Montgomery B, Schweizer MT, Hsieh AC, Lin DW, Corey E, Nelson PS, Morrissey C.

J Clin Invest. 2019 Jul 30;130:4492-4505. doi: 10.1172/JCI128212.

4.

Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy.

Winters BR, De Sarkar N, Arora S, Bolouri H, Jana S, Vakar-Lopez F, Cheng HH, Schweizer MT, Yu EY, Grivas P, Lee JK, Kollath L, Holt SK, McFerrin L, Ha G, Nelson PS, Montgomery RB, Wright JL, Lam HM, Hsieh AC.

JCI Insight. 2019 May 30;5. pii: 128728. doi: 10.1172/jci.insight.128728.

5.

Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations.

Schweizer MT, Antonarakis ES, Bismar TA, Guedes LB, Cheng HH, Tretiakova MS, Vakar-Lopez F, Klemfuss N, Konnick EQ, Mostaghel EA, Hsieh AC, Nelson PS, Yu EY, Montgomery RB, True LD, Epstein JI, Lotan TL, Pritchard CC.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00327. Epub 2019 Apr 18.

6.

The Untranslated Regions of mRNAs in Cancer.

Schuster SL, Hsieh AC.

Trends Cancer. 2019 Apr;5(4):245-262. doi: 10.1016/j.trecan.2019.02.011. Epub 2019 Mar 22. Review.

PMID:
30961831
7.

Development of a stress response therapy targeting aggressive prostate cancer.

Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D.

Sci Transl Med. 2018 May 2;10(439). pii: eaar2036. doi: 10.1126/scitranslmed.aar2036.

8.

Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy.

Winters BR, Vakar-Lopez F, Brown L, Montgomery B, Seiler R, Black PC, Boormans JL, Dall Era M, Davincioni E, Douglas J, Gibb EA, van Rhijn BWG, van der Heijden MS, Hsieh AC, Wright JL, Lam HM.

Urol Oncol. 2018 Jul;36(7):342.e7-342.e14. doi: 10.1016/j.urolonc.2018.03.016. Epub 2018 Apr 12.

9.

Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells.

Guzzi N, Cieśla M, Ngoc PCT, Lang S, Arora S, Dimitriou M, Pimková K, Sommarin MNE, Munita R, Lubas M, Lim Y, Okuyama K, Soneji S, Karlsson G, Hansson J, Jönsson G, Lund AH, Sigvardsson M, Hellström-Lindberg E, Hsieh AC, Bellodi C.

Cell. 2018 May 17;173(5):1204-1216.e26. doi: 10.1016/j.cell.2018.03.008. Epub 2018 Apr 5.

10.

A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.

Graham L, Banda K, Torres A, Carver BS, Chen Y, Pisano K, Shelkey G, Curley T, Scher HI, Lotan TL, Hsieh AC, Rathkopf DE.

Invest New Drugs. 2018 Jun;36(3):458-467. doi: 10.1007/s10637-018-0578-9. Epub 2018 Mar 6.

11.

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.

Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, Bianchi-Frias D, Dumpit RF, Kaipainen A, Corella AN, Yang YC, Nyquist MD, Mostaghel E, Hsieh AC, Zhang X, Corey E, Brown LG, Nguyen HM, Pienta K, Ittmann M, Schweizer M, True LD, Wise D, Rennie PS, Vessella RL, Morrissey C, Nelson PS.

Cancer Cell. 2017 Oct 9;32(4):474-489.e6. doi: 10.1016/j.ccell.2017.09.003.

12.
13.

A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer.

Wei XX, Hsieh AC, Kim W, Friedlander T, Lin AM, Louttit M, Ryan CJ.

Oncologist. 2017 May;22(5):503-e43. doi: 10.1634/theoncologist.2016-0432. Epub 2017 Mar 17.

14.

Safety of Statins in Chronic Hepatitis B Patients.

Huang YW, Hsieh AC, Yang SS.

Am J Gastroenterol. 2017 Feb;112(2):385-386. doi: 10.1038/ajg.2016.578. No abstract available.

PMID:
28154403
15.

Response to Hu et al.

Huang YW, Hsieh AC, Yang SS.

Am J Gastroenterol. 2017 Feb;112(2):383-384. doi: 10.1038/ajg.2016.549. No abstract available.

PMID:
28154397
16.

Response to Lo et al.

Huang YW, Hsieh AC, Yang SS.

Am J Gastroenterol. 2017 Feb;112(2):387-388. doi: 10.1038/ajg.2016.577. No abstract available.

PMID:
28154385
17.

Statins and the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients.

Huang YW, Hsieh AC, Yang SS.

Am J Gastroenterol. 2016 Nov;111(11):1655-1656. doi: 10.1038/ajg.2016.423. No abstract available.

PMID:
27808146
18.

Fundamental concerns of women living with HIV around the implementation of Option B+.

Matheson R, Moses-Burton S, Hsieh AC, Dilmitis S, Happy M, Sinyemu E, Brion SO, Sharma A.

J Int AIDS Soc. 2015 Dec 1;18(Suppl 5):20286. doi: 10.7448/IAS.18.6.20286. eCollection 2015.

19.

Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors.

Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D.

Sci Signal. 2015 Nov 17;8(403):ra116. doi: 10.1126/scisignal.aad5111.

20.

YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence.

Sheridan CM, Grogan TR, Nguyen HG, Galet C, Rettig MB, Hsieh AC, Ruggero D.

Oncotarget. 2015 Apr 10;6(10):7470-80.

21.

Community and service provider views to inform the 2013 WHO consolidated antiretroviral guidelines: key findings and lessons learnt.

Hsieh AC, Mburu G, Garner AB, Teltschik A, Ram M, Mallouris C, Penazzato M, Shaffer N, Easterbrook PJ, Ball A.

AIDS. 2014 Mar;28 Suppl 2:S205-16. doi: 10.1097/QAD.0000000000000251.

PMID:
24849480
22.

ADSC therapy in neurodegenerative disorders.

Chan TM, Chen JY, Ho LI, Lin HP, Hsueh KW, Liu DD, Chen YH, Hsieh AC, Tsai NM, Hueng DY, Tsai ST, Chou PW, Lin SZ, Harn HJ.

Cell Transplant. 2014;23(4-5):549-57. doi: 10.3727/096368914X678445. Review.

PMID:
24816450
23.

The use of ADSCs as a treatment for chronic stroke.

Chan TM, Harn HJ, Lin HP, Chiu SC, Lin PC, Wang HI, Ho LI, Chuu CP, Chiou TW, Hsieh AC, Chen YW, Ho WY, Lin SZ.

Cell Transplant. 2014;23(4-5):541-7. doi: 10.3727/096368914X678409. Review.

PMID:
24816449
24.

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance.

Edlind MP, Hsieh AC.

Asian J Androl. 2014 May-Jun;16(3):378-86. doi: 10.4103/1008-682X.122876. Review.

25.

Assessing gene-level translational control from ribosome profiling.

Olshen AB, Hsieh AC, Stumpf CR, Olshen RA, Ruggero D, Taylor BS.

Bioinformatics. 2013 Dec 1;29(23):2995-3002. doi: 10.1093/bioinformatics/btt533. Epub 2013 Sep 18.

26.

The translational landscape of mTOR signalling steers cancer initiation and metastasis.

Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, Shi EY, Stumpf CR, Christensen C, Bonham MJ, Wang S, Ren P, Martin M, Jessen K, Feldman ME, Weissman JS, Shokat KM, Rommel C, Ruggero D.

Nature. 2012 Feb 22;485(7396):55-61. doi: 10.1038/nature10912.

27.

A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine.

Lai JY, Hsieh AC.

Biomaterials. 2012 Mar;33(7):2372-87. doi: 10.1016/j.biomaterials.2011.11.085. Epub 2011 Dec 17.

PMID:
22182746
28.

Oncogenic AKTivation of translation as a therapeutic target.

Hsieh AC, Truitt ML, Ruggero D.

Br J Cancer. 2011 Jul 26;105(3):329-36. doi: 10.1038/bjc.2011.241. Epub 2011 Jul 19. Review.

29.

Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning.

Kondrashov N, Pusic A, Stumpf CR, Shimizu K, Hsieh AC, Ishijima J, Shiroishi T, Barna M.

Cell. 2011 Apr 29;145(3):383-397. doi: 10.1016/j.cell.2011.03.028.

30.

Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.

Hsieh AC, Ruggero D.

Clin Cancer Res. 2010 Oct 15;16(20):4914-20. doi: 10.1158/1078-0432.CCR-10-0433. Epub 2010 Aug 11.

31.

Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.

Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR, Meyuhas O, Shokat KM, Ruggero D.

Cancer Cell. 2010 Mar 16;17(3):249-61. doi: 10.1016/j.ccr.2010.01.021.

32.

Novel concepts in androgen receptor blockade.

Hsieh AC, Ryan CJ.

Cancer J. 2008 Jan-Feb;14(1):11-4. doi: 10.1097/PPO.0b013e318161d13e. Review.

PMID:
18303477
33.

Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development.

Hsieh AC, Small EJ, Ryan CJ.

Lancet Oncol. 2007 Oct;8(10):933-9. Review.

PMID:
17913662
34.

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

Hsieh AC, Moasser MM.

Br J Cancer. 2007 Aug 20;97(4):453-7. Epub 2007 Jul 31. Review.

35.

A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens.

Hsieh AC, Bo R, Manola J, Vazquez F, Bare O, Khvorova A, Scaringe S, Sellers WR.

Nucleic Acids Res. 2004 Feb 9;32(3):893-901. Print 2004.

36.

Effect of 5-HT3 receptor antagonist (ondansetron) on functioning human pancreatic carcinoid cells.

Ishizuka J, Hsieh AC, Townsend CM Jr, Thompson JC.

Surg Oncol. 1993 Aug;2(4):221-5.

PMID:
8252212
37.

Interaction of cold and starvation in the regulation of plasma corticosterone levels in the male rat.

Tang F, Hsieh AC, Lee CP, Baconshone J.

Horm Metab Res. 1984 Aug;16(8):445-8.

PMID:
6469211
38.

Effects of cold-acclimation on beta-adrenergic receptors of rabbit carotid artery.

Flaim SF, Hsieh AC.

Gen Pharmacol. 1979;10(3):275-7. No abstract available.

PMID:
38185
39.

Effect of cold-acclimation on rabbit carotid artery: altered response to norepinephrine.

Flaim SF, Hsieh AC.

Gen Pharmacol. 1978;9(6):437-42. No abstract available.

PMID:
730028
40.

Calorigenic effect of norepinephrine in newborn rats.

Hsieh AC, Emery N, Carlson LD.

Am J Physiol. 1971 Dec;221(6):1568-71. No abstract available.

PMID:
5124301
41.

Calorigenic responses to cold of rats after prolonged infusion of norepinephrine.

Hsieh AC, Wang JC.

Am J Physiol. 1971 Jul;221(1):335-7. No abstract available.

PMID:
5555805
42.

Circulatory and metabolic effects of noradrenaline in cold-adapted rats.

Hsieh AC, Pun CW, Li KM, Ti KW.

Fed Proc. 1966 Jul-Aug;25(4):1205-12. No abstract available.

PMID:
5913888
43.

EFFECTS OF IMMERSION OF THE HAND IN COLD WATER ON DIGITAL BLOOD FLOW.

HSIEH AC, NAGASAKA T, CARLSON LD.

J Appl Physiol. 1965 Jan;20:61-4. No abstract available.

PMID:
14257562
44.

DIGITAL BLOOD FLOW AND DISTENSIBILITY DURING IMMERSION IN COLD WATER.

HSIEH AC, NAGASAKA T, CARLSON LD.

Proc Soc Exp Biol Med. 1964 Oct;117:105-7. No abstract available.

PMID:
14219915
45.

THE BASAL METABOLIC RATE OF COLD-ADAPTED RATS.

HSIEH AC.

J Physiol. 1963 Dec;169:851-61. No abstract available.

47.

The role of the thyroid in rats exposed to cold.

HSIEH AC.

J Physiol. 1962 Apr;161:175-88. No abstract available.

48.

The effects of L-thyroxine and cold-exposure on the amount of food consumed and absorbed by male albino rats.

Hsieh AC, Ti KW.

J Nutr. 1960 Nov;72(3):283-8. doi: 10.1093/jn/72.3.283. No abstract available.

PMID:
13716371
49.

A comparative study of four means of expressing the metabolic rate of rats.

CHIU CC, HSIEH AC.

J Physiol. 1960 Mar;150:694-706. No abstract available.

50.

Role of the sympathetic nervous system in the control of chemical regulation of heat production.

HSIEH AC, CARLSON LD, GRAY G.

Tech Rep Arct Aeromed Lab US. 1959 Nov;57-30:1-9. No abstract available.

PMID:
14403582

Supplemental Content

Loading ...
Support Center